RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 1 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,000 | +22.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,840 | +172.1% | 4,000 | +150.0% | 0.00% | +200.0% |
| Q1 2023 | $3,616 | -35.2% | 1,600 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $5,584 | -90.5% | 1,600 | 0.0% | 0.00% | -88.9% |
| Q3 2022 | $59,000 | +96.7% | 1,600 | 0.0% | 0.02% | +100.0% |
| Q2 2022 | $30,000 | -30.2% | 1,600 | 0.0% | 0.01% | -18.2% |
| Q1 2022 | $43,000 | +19.4% | 1,600 | 0.0% | 0.01% | +22.2% |
| Q4 2021 | $36,000 | -14.3% | 1,600 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $42,000 | -17.6% | 1,600 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $51,000 | -8.9% | 1,600 | 0.0% | 0.01% | -6.7% |
| Q1 2021 | $56,000 | +9.8% | 1,600 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $51,000 | +8.5% | 1,600 | 0.0% | 0.02% | 0.0% |
| Q3 2020 | $47,000 | – | 1,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |